Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults-Reference-Cited by-同舟云学术

Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

Published:2017-02 Issue:2 Volume:35 Page:88-99
ISSN:0213-005X
Container-title:Enfermedades Infecciosas y Microbiología Clínica
language:en
Short-container-title:Enfermedades Infecciosas y Microbiología Clínica

Author:

Rivero Antonio,Pérez-Molina José Antonio,Blasco Antonio Javier,Arribas José Ramón,Crespo Manuel,Domingo Pere,Estrada Vicente,Iribarren José Antonio,Knobel Hernando,Lázaro Pablo,López-Aldeguer José,Lozano Fernando,Moreno Santiago,Palacios Rosario,Pineda Juan Antonio,Pulido Federico,Rubio Rafael,de la Torre Javier,Tuset Montserrat,Gatell Josep M.

Publisher

Elsevier BV

Subject

Microbiology (medical)

Reference59 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators;Palella;N Engl J Med,1998

2. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group;Mocroft;Lancet,1998

3. Survival of persons with and without HIV infection in Denmark, 1995–2005;Lohse;Ann Intern Med,2007

4. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study;May;BMJ,2011

5. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease;Autran;Science,1997

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain;FARM HOSP;2022

2. Analysis of adherence to HIV-positive quality of care indicators and their impact on service quality perceptions in patients: a Spanish cross-sectional study;Health and Quality of Life Outcomes;2020-06-15

3. Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults;Enfermedades Infecciosas y Microbiología Clínica;2019-03

4. Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults;Enfermedades infecciosas y microbiologia clinica (English ed.);2019-03

5. Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain;PLOS ONE;2018-11-05